Data Snapshot - Hereditary Transthyretin Amyloidosis with Polyneuropathy

The HSE Medicines Management Programme provide insights into prescribing trends and utilisation for medicines and non-drug products available through the HSE. This Data Snapshot provides an update on utilisation of high tech medicines for hereditary transthyretin amyloidosis with polyneuropathy reimbursed subject to a managed access protocol.